These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19622727)

  • 21. Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
    Perche F; Uchida S; Akiba H; Lin CY; Ikegami M; Dirisala A; Nakashima T; Itaka K; Tsumoto K; Kataoka K
    Curr Alzheimer Res; 2017; 14(3):295-302. PubMed ID: 27829339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice.
    Walker LC; Callahan MJ; Bian F; Durham RA; Roher AE; Lipinski WJ
    Peptides; 2002 Jul; 23(7):1241-7. PubMed ID: 12128081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly potent intracellular membrane-associated Aβ seeds.
    Marzesco AM; Flötenmeyer M; Bühler A; Obermüller U; Staufenbiel M; Jucker M; Baumann F
    Sci Rep; 2016 Jun; 6():28125. PubMed ID: 27311744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aβ oligomers trigger and accelerate Aβ seeding.
    Katzmarski N; Ziegler-Waldkirch S; Scheffler N; Witt C; Abou-Ajram C; Nuscher B; Prinz M; Haass C; Meyer-Luehmann M
    Brain Pathol; 2020 Jan; 30(1):36-45. PubMed ID: 31099449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altering Brain Amyloidosis by Intra-Lingual and Extra-Nasal Exposure of Aβ Aggregates.
    Gamez N; Bravo-Alegria J; Huang Y; Perez-Urrutia N; Dongarwar D; Soto C; Morales R
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.
    Bolmont T; Clavaguera F; Meyer-Luehmann M; Herzig MC; Radde R; Staufenbiel M; Lewis J; Hutton M; Tolnay M; Jucker M
    Am J Pathol; 2007 Dec; 171(6):2012-20. PubMed ID: 18055549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Titration of biologically active amyloid-β seeds in a transgenic mouse model of Alzheimer's disease.
    Morales R; Bravo-Alegria J; Duran-Aniotz C; Soto C
    Sci Rep; 2015 Mar; 5():9349. PubMed ID: 25879692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis.
    Paganetti P; Antoniello K; Devraj K; Toni N; Kieran D; Madani R; Pihlgren M; Adolfsson O; Froestl W; Schrattenholz A; Liebner S; Havas D; Windisch M; Cirrito JR; Pfeifer A; Muhs A
    J Alzheimers Dis; 2014; 38(4):767-86. PubMed ID: 24072071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encephalopathy induced by Alzheimer brain inoculation in a non-human primate.
    Gary C; Lam S; Hérard AS; Koch JE; Petit F; Gipchtein P; Sawiak SJ; Caillierez R; Eddarkaoui S; Colin M; Aujard F; Deslys JP; ; Brouillet E; Buée L; Comoy EE; Pifferi F; Picq JL; Dhenain M
    Acta Neuropathol Commun; 2019 Sep; 7(1):126. PubMed ID: 31481130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
    Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
    J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage.
    Nikolic WV; Bai Y; Obregon D; Hou H; Mori T; Zeng J; Ehrhart J; Shytle RD; Giunta B; Morgan D; Town T; Tan J
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2507-12. PubMed ID: 17264212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E22Q-mutant Abeta peptide (AbetaDutch) increases vascular but reduces parenchymal Abeta deposition.
    Herzig MC; Eisele YS; Staufenbiel M; Jucker M
    Am J Pathol; 2009 Mar; 174(3):722-6. PubMed ID: 19218342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice.
    Kawahara K; Suenobu M; Yoshida A; Koga K; Hyodo A; Ohtsuka H; Kuniyasu A; Tamamaki N; Sugimoto Y; Nakayama H
    Neuroscience; 2012 Apr; 207():243-60. PubMed ID: 22342341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation.
    Obregon D; Hou H; Bai Y; Nikolic WV; Mori T; Luo D; Zeng J; Ehrhart J; Fernandez F; Morgan D; Giunta B; Town T; Tan J
    Neurobiol Dis; 2008 Feb; 29(2):336-53. PubMed ID: 18055209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenously Injected Amyloid-β Peptide With Isomerized Asp7 and Phosphorylated Ser8 Residues Inhibits Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice Model of Alzheimer's Disease.
    Kozin SA; Barykin EP; Telegin GB; Chernov AS; Adzhubei AA; Radko SP; Mitkevich VA; Makarov AA
    Front Neurosci; 2018; 12():518. PubMed ID: 30210271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
    Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
    Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for the experimental transmission of cerebral beta-amyloidosis to primates.
    Baker HF; Ridley RM; Duchen LW; Crow TJ; Bruton CJ
    Int J Exp Pathol; 1993 Oct; 74(5):441-54. PubMed ID: 8217779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
    Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM
    FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.